Searched for
GENERIC NAMES
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- PMS vs mutual funds: 5 reasons to invest, and 5 red flags to watchPortfolio Management Services (PMS) offer structural advantages over mutual funds, allowing for concentrated portfolios, significant cash h...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...
- A 2026 World Cup tech makeover is turning every player into a digital twin, with 16 cameras, a 13-gram smart ball, and millimeter-level scans that could settle the sport’s tightest callsThe World Cup introduces a revolutionary AI offside system. Players are now 3D scanned, and a smart ball tracks every touch. This technolog...
- The accounting trick used by companies to make a weak balance sheet look strongIn one recent case, a large investment sat comfortably under equity until the auditor read the shareholders' agreement, found a buyback cla...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- PM had time to speak about mangoes, but not about 18.5 lakh children: Rahul Gandhi on CBSE OSM rowThe leader of opposition in the Lok Sabha said Prime Minister Modi's silence on the Central Board of Secondary Education's (CBSE) On-Screen...
- Instagram emerges as platform for anti-caste Indian artDalit and Bahujan artists are reshaping the landscape of digital expression, turning social media into dynamic exhibitions of resistance. T...
- Netflix’s hiring process for $7,000 jobs: upGrad founder reveals why 97% resumes fail and one key mistake candidates makeSecuring a job at tech giants like Netflix and Amazon is a tough challenge. Vishva Mohan, CEO of upGrad School of Technology, revealed that...
- Boss's tactic to ruin ex-worker’s reference check in next company backfires. What the employee did next led to apologyA Reddit user described how their job search repeatedly failed at the final stage despite strong interviews, with rejections consistently c...
- Be stock-specific, look for bargains: Daljeet Kohli on Nifty at 24,000 and top sector picksMarket expert Daljeet Kohli advises investors to focus on quality stocks at discounted prices, rather than the Nifty's movement. He highlig...
- Buy, Sell or Hold: Citi maintains buy on Eicher Motors; Goldman Sachs retains buy on Max HealthcareBrokerages maintain a positive outlook on select large-cap pharmaceutical, automobile, and healthcare stocks, citing strong growth prospect...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Bernstein initiates coverage on 6 pharma stocks, cites 3 major tailwinds for healthcare sectorBernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...
- No new Khata for revenue land acquired through partition deed in Bengaluru? Expert explains the available optionsBengaluru property owners face a new hurdle. The city's e-Khata portal does not allow new Khata creation for revenue land acquired through ...
- Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...
- AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...
Load More
